Exercise echocardiography in the detection of anthracycline cardiotoxicity
- 15 July 1991
- Vol. 68 (2) , 435-438
- https://doi.org/10.1002/1097-0142(19910715)68:2<435::aid-cncr2820680237>3.0.co;2-#
Abstract
Twenty long-term survivors of childhood cancer underwent exercise echocardiography to evaluate possible late anthracycline-induced cardiac toxicity. Ten patients ages 10 to 20 years had received anthracyclines, and ten patients ages 8 to 27 years had not received anthracyclines as part of their medical regimen. Both groups had normal cardiac function at rest. Patients who had not received anthracyclines had a greater increase in M-mode shortening fraction (P less than 0.005), velocity of circumferential fiber shortening (P = 0.05), and Doppler aortic peak flow velocity (P = 0.01) than patients receiving anthracyclines. There were no significant differences in work performed, or increase in heart rate or blood pressure with exercise between the groups. These results suggest that subtle abnormalities in myocardial function exist which become apparent only after exercise in survivors of childhood cancer who have received anthracyclines and have normal resting cardiac function.Keywords
This publication has 5 references indexed in Scilit:
- Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancerThe Journal of Pediatrics, 1990
- Long-term Complications of Therapy for Cancer in Childhood and AdolescencePublished by Springer Nature ,1989
- Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and reviewThe American Journal of Medicine, 1986
- Two sensitive echocardiographic techniques for detecting doxorubicin toxicityMedical and Pediatric Oncology, 1983
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979